NEXIEN BIOPHARMA, INC. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q3 2014 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Nexien Biopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2014 to Q3 2024.
- Nexien Biopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending September 30, 2024 was -$9.23K, a 46% increase year-over-year.
- Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$64.4K, a 21.3% increase from 2023.
- Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$81.8K, a 8.79% decline from 2022.
- Nexien Biopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$75.1K, a 17.2% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)